-
Je něco špatně v tomto záznamu ?
Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I
T. Danhelovska, H. Kolarova, J. Zeman, H. Hansikova, M. Vaneckova, L. Lambert, V. Kucerova-Vidrova, K. Berankova, T. Honzik, M. Tesarova,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
AZV 17-30965A
Ministerstvo Zdravotnictví Ceské Republiky - International
RVO VFN 64165
Ministerstvo Zdravotnictví Ceské Republiky - International
Q26/LF1
Univerzita Karlova v Praze - International
UNCE 204064
Univerzita Karlova v Praze - International
SVV260367
Univerzita Karlova v Praze - International
NLK
BioMedCentral
od 2001-01-12
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-02-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- biopsie MeSH
- dítě MeSH
- dospělí MeSH
- fibroblasty metabolismus MeSH
- kojenec MeSH
- kosterní svaly metabolismus MeSH
- kultivované buňky MeSH
- Leighova nemoc genetika MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mitochondriální DNA * MeSH
- mitochondriální nemoci genetika MeSH
- mladiství MeSH
- mozek diagnostické zobrazování patologie MeSH
- mutace * MeSH
- novorozenec MeSH
- respirační komplex I nedostatek genetika metabolismus MeSH
- syndrom MELAS genetika MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Maternally inherited complex I deficiencies due to mutations in MT-ND genes represent a heterogeneous group of multisystem mitochondrial disorders (MD) with a unfavourable prognosis. The aim of the study was to characterize the impact of the mutations in MT-ND genes, including the novel m.13091 T > C variant, on the course of the disease, and to analyse the activities of respiratory chain complexes, the amount of protein subunits, and the mitochondrial energy-generating system (MEGS) in available muscle biopsies and cultivated fibroblasts. METHODS: The respiratory chain complex activities were measured by spectrophotometry, MEGS were analysed using radiolabelled substrates, and protein amount by SDS-PAGE or BN-PAGE in muscle or fibroblasts. RESULTS: In our cohort of 106 unrelated families carrying different mtDNA mutations, we found heteroplasmic mutations in the genes MT-ND1, MT-ND3, and MT-ND5, including the novel variant m.13091 T > C, in 13 patients with MD from 12 families. First symptoms developed between early childhood and adolescence and progressed to multisystem disease with a phenotype of Leigh or MELAS syndromes. MRI revealed bilateral symmetrical involvement of deep grey matter typical of Leigh syndrome in 6 children, cortical/white matter stroke-like lesions suggesting MELAS syndrome in 3 patients, and a combination of cortico-subcortical lesions and grey matter involvement in 4 patients. MEGS indicated mitochondrial disturbances in all available muscle samples, as well as a significantly decreased oxidation of [1-14C] pyruvate in fibroblasts. Spectrophotometric analyses revealed a low activity of complex I and/or complex I + III in all muscle samples except one, but the activities in fibroblasts were mostly normal. No correlation was found between complex I activities and mtDNA mutation load, but higher levels of heteroplasmy were generally found in more severely affected patients. CONCLUSIONS: Maternally inherited complex I deficiencies were found in 11% of families with mitochondrial diseases in our region. Six patients manifested with Leigh, three with MELAS. The remaining four patients presented with an overlap between these two syndromes. MEGS, especially the oxidation of [1-14C] pyruvate in fibroblasts might serve as a sensitive indicator of functional impairment due to MT-ND mutations. Early onset of the disease and higher level of mtDNA heteroplasmy were associated with a worse prognosis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025255
- 003
- CZ-PrNML
- 005
- 20201222153754.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12887-020-1912-x $2 doi
- 035 __
- $a (PubMed)31996177
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Danhelovska, Tereza $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 245 10
- $a Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I / $c T. Danhelovska, H. Kolarova, J. Zeman, H. Hansikova, M. Vaneckova, L. Lambert, V. Kucerova-Vidrova, K. Berankova, T. Honzik, M. Tesarova,
- 520 9_
- $a BACKGROUND: Maternally inherited complex I deficiencies due to mutations in MT-ND genes represent a heterogeneous group of multisystem mitochondrial disorders (MD) with a unfavourable prognosis. The aim of the study was to characterize the impact of the mutations in MT-ND genes, including the novel m.13091 T > C variant, on the course of the disease, and to analyse the activities of respiratory chain complexes, the amount of protein subunits, and the mitochondrial energy-generating system (MEGS) in available muscle biopsies and cultivated fibroblasts. METHODS: The respiratory chain complex activities were measured by spectrophotometry, MEGS were analysed using radiolabelled substrates, and protein amount by SDS-PAGE or BN-PAGE in muscle or fibroblasts. RESULTS: In our cohort of 106 unrelated families carrying different mtDNA mutations, we found heteroplasmic mutations in the genes MT-ND1, MT-ND3, and MT-ND5, including the novel variant m.13091 T > C, in 13 patients with MD from 12 families. First symptoms developed between early childhood and adolescence and progressed to multisystem disease with a phenotype of Leigh or MELAS syndromes. MRI revealed bilateral symmetrical involvement of deep grey matter typical of Leigh syndrome in 6 children, cortical/white matter stroke-like lesions suggesting MELAS syndrome in 3 patients, and a combination of cortico-subcortical lesions and grey matter involvement in 4 patients. MEGS indicated mitochondrial disturbances in all available muscle samples, as well as a significantly decreased oxidation of [1-14C] pyruvate in fibroblasts. Spectrophotometric analyses revealed a low activity of complex I and/or complex I + III in all muscle samples except one, but the activities in fibroblasts were mostly normal. No correlation was found between complex I activities and mtDNA mutation load, but higher levels of heteroplasmy were generally found in more severely affected patients. CONCLUSIONS: Maternally inherited complex I deficiencies were found in 11% of families with mitochondrial diseases in our region. Six patients manifested with Leigh, three with MELAS. The remaining four patients presented with an overlap between these two syndromes. MEGS, especially the oxidation of [1-14C] pyruvate in fibroblasts might serve as a sensitive indicator of functional impairment due to MT-ND mutations. Early onset of the disease and higher level of mtDNA heteroplasmy were associated with a worse prognosis.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a mozek $x diagnostické zobrazování $x patologie $7 D001921
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a mitochondriální DNA $7 D004272
- 650 _2
- $a respirační komplex I $x nedostatek $x genetika $x metabolismus $7 D042967
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblasty $x metabolismus $7 D005347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a Leighova nemoc $x genetika $7 D007888
- 650 _2
- $a syndrom MELAS $x genetika $7 D017241
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mitochondriální nemoci $x genetika $7 D028361
- 650 _2
- $a kosterní svaly $x metabolismus $7 D018482
- 650 12
- $a mutace $7 D009154
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kolarova, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Hansikova, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Kucerova-Vidrova, Vendula $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Berankova, Kamila $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Honzik, Tomas $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic.
- 700 1_
- $a Tesarova, Marketa $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 128 08 Praha 2, Prague, Czech Republic. marketa.tesarova@lf1.cuni.cz.
- 773 0_
- $w MED00008201 $t BMC pediatrics $x 1471-2431 $g Roč. 20, č. 1 (2020), s. 41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31996177 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153750 $b ABA008
- 999 __
- $a ok $b bmc $g 1599400 $s 1115941
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 20 $c 1 $d 41 $e 20200129 $i 1471-2431 $m BMC pediatrics $n BMC Pediatr $x MED00008201
- GRA __
- $a AZV 17-30965A $p Ministerstvo Zdravotnictví Ceské Republiky $2 International
- GRA __
- $a RVO VFN 64165 $p Ministerstvo Zdravotnictví Ceské Republiky $2 International
- GRA __
- $a Q26/LF1 $p Univerzita Karlova v Praze $2 International
- GRA __
- $a UNCE 204064 $p Univerzita Karlova v Praze $2 International
- GRA __
- $a SVV260367 $p Univerzita Karlova v Praze $2 International
- LZP __
- $a Pubmed-20201125